Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20,000
- 试验地点
- 1
- 主要终点
- All due to readmission
研究概览
简要总结
This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All patients admitted to the Department of Cardiovascular Medicine at The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, The Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin Chest Hospital, Tianjin Hospital of ITCWM Nankai Hospital and Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital were considered for inclusion in this study, and all Western medical diagnoses were identified and classified according to the International Classification of Diseases, 11th Revision (ICD-11).
排除标准
- •No exclusion criteria.
研究组 & 干预措施
Exposed group
Western medicine treatment with Chinese medicine treatmen
干预措施: Chinese patent medicine (Drug)
结局指标
主要结局
All due to readmission
时间窗: one year
Readmission for cardiovascular events and readmission for other reasons.
Cardiovascular Events Cardiovascular Events Cardiovascular Events
时间窗: one year
Non-fatal myocardial infarction, non-fatal ischemic stroke, unplanned hemodynamic reconstruction.
All due to death
时间窗: one year
Cardiac death and death from other causes.
次要结局
未报告次要终点
研究者
Lin Li
researcher
Tianjin University of Traditional Chinese Medicine